General Information of Drug (ID: DMSH4DG)

Drug Name
Silibinin Drug Info
Synonyms
silibinin; Silybin; 22888-70-6; Flavobin; Silymarin I; Silybin A; Silybine; Silibinine; Silliver; Silibinin A; Silibininum; Silibinina; Flavobin Spofa; Silymarine I; Silibinin [INN]; Silymarine; Silibininum [INN-Latin]; Silibinine [INN-French]; Silibinina [INN-Spanish]; 7C3MT; UNII-33X338MNE4; EINECS 245-302-5; NSC 651520; Silimarin; Silibin; CHEBI:9144; 33X338MNE4; Silibinin (INN); NSC651520; C25H22O10; NCGC00091057-01; DSSTox_CID_6018; DSSTox_RID_77985; DSSTox_GSID_26018; (2R,3R)-3,5,7-trihydroxy-2-((2R,3R)-3-(4-hydroxy-
Cross-matching ID
PubChem CID
31553
ChEBI ID
CHEMBL431701
CAS Number
CAS 22888-70-6
TTD Drug ID
D02ADM

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 2.29 0.00e+0 34/36 (94.44%) PCNA;PRIM1;MCM6;...
Mismatch repair 1.84 3.80e-2 22/23 (95.65%) PCNA;MSH2;RFC4;...
Renin-angiotensin system -1.64 4.61e-2 20/23 (86.96%) ACE2;AGTR1;KLK1;...
Morphine addiction -1.64 4.83e-2 80/91 (87.91%) DRD1;GNAO1;GABRA5;...
Long-term potentiation -1.64 4.95e-2 61/67 (91.04%) GRIN2C;ITPR2;PLCB2;...
Bile secretion -1.65 4.94e-2 68/90 (75.56%) ABCB4;ABCB11;SLC22A8;...
Neurotrophin signaling pathway -1.65 4.93e-2 107/119 (89.92%) MAPK8;AKT1;RPS6KA1;...
Amoebiasis -1.66 4.07e-2 99/102 (97.06%) C8A;LAMC2;COL4A6;...
Epithelial cell signaling in Helicobacter pylori infect... -1.67 3.92e-2 62/70 (88.57%) ATP6V1A;MAP2K4;TJP1;...
Tyrosine metabolism -1.68 3.93e-2 30/36 (83.33%) ADH6;ADH1C;ADH1A;...
Long-term depression -1.69 3.76e-2 55/60 (91.67%) PPP2R1B;GNAO1;RAF1;...
Serotonergic synapse -1.70 3.96e-2 97/114 (85.09%) TPH1;CACNA1D;HRAS;...
Alcoholism -1.71 3.53e-2 86/186 (46.24%) GNB3;PPP1CC;CRH;...
Dopaminergic synapse -1.73 3.26e-2 115/132 (87.12%) ITPR2;PLCB2;CAMK2A;...
Glutamatergic synapse -1.74 3.48e-2 97/114 (85.09%) GRM8;GNAO1;GRK3;...
Legionellosis -1.74 3.91e-2 51/57 (89.47%) RELA;NFKB2;NFKBIA;...
GABAergic synapse -1.76 2.86e-2 76/89 (85.39%) KCNJ6;GABBR2;PLCL1;...
Ascorbate and aldarate metabolism -1.80 2.09e-2 15/30 (50%) ALDH1B1;UGT2A3;UGDH;...
Gap junction -1.88 7.51e-3 72/88 (81.82%) PDGFD;MAP2K1;PRKCB;...
Cholesterol metabolism -1.89 9.39e-3 44/50 (88%) APOC1;TSPO;PLTP;...
Regulation of lipolysis in adipocytes -1.95 4.17e-3 52/55 (94.55%) PIK3CD;ABHD5;MGLL;...
Complement and coagulation cascades -2.05 6.26e-3 76/85 (89.41%) C1S;PLAUR;CFHR2;...
Cocaine addiction -2.07 1.25e-2 42/49 (85.71%) MAOB;RELA;RGS9;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.04uM - 20uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.04uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 20uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 0.04uM - 10uM 24H
Peripheral blood
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.04uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.04uM - 20uM 6H, 24H